Items | Total | Score range | Mean rating |
---|---|---|---|
1. Infectious disease management | |||
1.1 Multidisciplinary team construction | 45 | 36.8 ± 5.5 | 81.9% |
1.2 Procurement | 20 | 17.5 ± 2.8 | 87.3% |
1.3 β-lactam skin test | 10 | 8.4 ± 1.8 | 84.0% |
2. Antibacterial usage surveillance | |||
2.1 Data report | 12 | 11.3 ± 1.7 | 93.9% |
2.2 Management practices | 18 | 16.3 ± 2.6 | 90.7% |
2.3 Antibacterial usage indicators | 20 | 16.9 ± 3.6 | 84.5% |
2.4 Focused antibiotics usage intensity | 50 | 38.8 ± 8.0 | 77.7% |
3. Antibacterial resistance surveillance | |||
3.1 Specimen quality & quantity | 20 | 10.9 ± 4.0 | 54.7% |
3.2 Antibacterial susceptibility testing | 30 | 18.4 ± 6.2 | 61.4% |
3.3 Focused drug-resistance pathogens | 50 | 24.6 ± 9.9 | 49.1% |
4. Fungal diseases surveillance | |||
4.1 Participation & data quality | 33 | 11.9 ± 12.2 | 36.0% |
4.2 Training | 6 | 3.0 ± 2.8 | 50.0% |
4.3 Diagnostic capability | 36 | 22.8 ± 6.6 | 63.3% |
5. Hospital infection surveillance | |||
5.1 Informatization | 30 | 26.4 ± 4.6 | 88.1% |
5.2 Hospital infection indicators | 62 | 43.6 ± 9.1 | 70.4% |
5.3 Infection prevention & control | 8 | 7.1 ± 0.8 | 88.3% |